25 January 2022

HemaVision® Leukemia Screening Tool

We see an increased demand for a reliable screening tool to detect chromosomal translocations associated with Leukemia.

This can be achieved by HemaVision, fast and efficiently, by a simple and rapid protocol. HemaVision screens for 28 translocations simultaneously. An ideal CE-IVD marked tool for the initial screening of patients with Leukemia.


HemaVision®-28Q is a screening tool for the initial screening of Leukemia patients. The analysis time is 4 hours, includes only 2 pipetting steps and a final interpretation step. The kit is ready-to-use upon delivery; the cDNA mix and qPCR mixes are pre-aliquoted into the tubes, of which the qPCR tubes fit your qPCR instrument of choice.

This kit gives you an ideal foundation for making a fast diagnosis of your patient, since it screens for 28 translocations simultaneously.

HemaVision®-28Q (HV01-28Q)
HemaVision® products are CE-IVD marked and have received a Free Sales Document.

Related articles

Newsletter for researchers

We gladly support you by keeping you updated on our latest products and the developments around our services.

we Connect you
Need help? Contact our technical support